Last reviewed · How we verify
Sensodyne Rapid Relief
At a glance
| Generic name | Sensodyne Rapid Relief |
|---|---|
| Sponsor | HALEON |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Study to Investigate the Ability of a Stannous Fluoride Toothpaste to Protect From Dentine Hypersensitivity (NA)
- Efficacy of Formulated Eggshell Derived Nano-hydroxyapatite Containing Toothpaste With and Without Addition of Fluoride vs. Conventional Desensitizing Fluoride Containing Toothpaste in Management of Dentin Hypersensitivity (PHASE1)
- Clinical Efficacy Of BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In DH (PHASE3)
- Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions (NA)
- Reduction of Dentine Hypersensitivity Using 8% Arginine Based Toothpaste and 8% Strontium Acetate Based Toothpaste (DH) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sensodyne Rapid Relief CI brief — competitive landscape report
- Sensodyne Rapid Relief updates RSS · CI watch RSS
- HALEON portfolio CI